Kaempferol-induced GPER Upregulation Attenuates Atherosclerosis Via the PI3K/AKT/Nrf2 Pathway
Overview
Affiliations
Context: The effect of kaempferol, a regulator of oestrogen receptors, on atherosclerosis (AS) and the underlying mechanism is elusive.
Objective: To explore the effect and mechanism of kaempferol on AS.
Methods And Materials: , C57BL/6 and apolipoprotein E (APOE) mice were randomly categorized into six groups (C57BL/6: control, ovariectomy (OVX), high-fat diet (HFD); APOE: OVX-HFD, OVX-HFD + kaempferol (50 mg/kg) and OVX-HFD + kaempferol (100 mg/kg) and administered with kaempferol for 16 weeks, intragastrically. Oil-Red and haematoxylin-eosin (HE) staining were employed to examine the effect of kaempferol. , human aortic endothelial cells (HAECs) were pre-treated with or without kaempferol (5, 10 or 20 μM), followed by administration with kaempferol and oxidized low-density lipoprotein (ox-LDL) (200 μg/mL). The effect of kaempferol was evaluated using flow cytometry, and TdT-mediated dUTP Nick-End Labelling (TUNEL).
Results: , kaempferol (50 and 100 mg/kg) normalized the morphology of blood vessels and lipid levels and suppressed inflammation and apoptosis. It also activated the G protein-coupled oestrogen receptor (GPER) and PI3K/AKT/nuclear factor-erythroid 2-related factor 2 (Nrf2) pathways. , ox-LDL (200 μg/mL) reduced the cell viability to 50% (IC). Kaempferol (5, 10 or 20 μM) induced-GPER activation increased cell viability to nearly 10%, 19.8%, 30%, and the decreased cellular reactive oxygen species (ROS) generation (16.7%, 25.6%, 31.1%), respectively, consequently attenuating postmenopausal AS. However, the protective effects of kaempferol were blocked through co-treatment with si-GPER.
Conclusions: The beneficial effects of kaempferol against postmenopausal AS are associated with the PI3K/AKT/Nrf2 pathways, mediated by the activation of GPER.
Upadhayay S, Uttam V, Kumar P Neurochem Res. 2025; 50(2):119.
PMID: 40087195 DOI: 10.1007/s11064-025-04369-z.
Wang Z, Wu F, Yan J, Liang L, Chang F, Dong M J Cell Mol Med. 2025; 29(5):e70446.
PMID: 40045169 PMC: 11882393. DOI: 10.1111/jcmm.70446.
Cardiovascular protective effects of natural flavonoids on intestinal barrier injury.
Zhou P, Xu H, Wang L Mol Cell Biochem. 2025; .
PMID: 39820766 DOI: 10.1007/s11010-025-05213-2.
Lai Y, Tang Z, Du Z, Zeng Q, Xia Y, Chen S Endocrine. 2024; 87(3):1276-1284.
PMID: 39565544 PMC: 11845544. DOI: 10.1007/s12020-024-04106-6.
Ning B, Zhu X, Wu X, Zhu W, Wang R, Qi C Front Pharmacol. 2024; 15:1486458.
PMID: 39555103 PMC: 11565597. DOI: 10.3389/fphar.2024.1486458.